We are live on ! Find out more
PEPL

PepperLime Health Acquisition Corporation Class A Ordinary Share

Delisted

PEPL was delisted on the 21st of March, 2024.

43 hedge funds and large institutions have $172M invested in PepperLime Health Acquisition Corporation Class A Ordinary Share in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $152M → $172M (+$20.1M)

0% more funds holding

Funds holding: 4343 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
43
Holders Change
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
6
Reduced
10
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$15.2M
RCM
2
Rivernorth Capital Management
Florida
$15.2M
SCM
3
Shaolin Capital Management
Florida
$10.7M
RCM
4
Radcliffe Capital Management
Pennsylvania
$10.5M
SIM
5
Sandia Investment Management
Massachusetts
$9.73M +$9.61M +952,921 New
Millennium Management
6
Millennium Management
New York
$8.29M -$172 -17 -0%
CSS
7
Cubist Systematic Strategies
Connecticut
$8.1M -$102K -10,085 -1%
Marshall Wace
8
Marshall Wace
United Kingdom
$7.65M
ACM
9
Altium Capital Management
New York
$7.5M
Calamos Advisors
10
Calamos Advisors
Illinois
$7.15M
WCMNY
11
Westchester Capital Management (New York)
New York
$7.07M +$6.44M +638,625 +1,210%
HSBC Holdings
12
HSBC Holdings
United Kingdom
$6.95M
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$6.81M +$1.02K +101 +0%
MF
14
Magnetar Financial
Illinois
$6.72M
HCM
15
Highbridge Capital Management
New York
$4.86M -$4.15M -411,225 -46%
PC
16
Periscope Capital
Ontario, Canada
$4.74M +$17.5K +1,737 +0.4%
AA
17
AQR Arbitrage
Connecticut
$3.97M
KC
18
Kepos Capital
New York
$3.51M +$3.47M +343,916 New
GCL
19
Glazer Capital LLC
New York
$3.48M +$632K +62,608 +22%
FTCM
20
First Trust Capital Management
Illinois
$3.3M +$3.26M +322,725 New
SCM
21
Saba Capital Management
New York
$3.02M +$575 +57 +0%
LA
22
Linden Advisors
New York
$2.91M
BFM
23
Boothbay Fund Management
New York
$2.7M +$2.67M +264,640 New
FTCM
24
Fir Tree Capital Management
New York
$2.39M -$27.6K -2,738 -1%
KL
25
KIM LLC
Kansas
$2.31M +$2.29M +226,526 New

PEPL Hedge Fund Activity: Q4 2022 in Review

43 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) for Q4 2022, worth a combined $172M — up 13% from $152M a quarter earlier.

Fund positioning in PEPL was balanced in Q4 2022: 7 funds opened new positions, 7 closed out, 6 added to existing stakes and 10 trimmed.

The largest buyer was Sandia Investment Management, opening a new position worth an estimated $9.61M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $4.15M sold.

  • 43 institutional investors held PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $172M of PepperLime Health Acquisition Corporation Class A Ordinary Share stock for Q4 2022, up 13% quarter-over-quarter.
  • 7 funds opened new PepperLime Health Acquisition Corporation Class A Ordinary Share positions in Q4 2022 and 7 closed out, a net change of 0 holders.
  • The largest PepperLime Health Acquisition Corporation Class A Ordinary Share buyer in Q4 2022 was Sandia Investment Management, an estimated $9.61M added.
  • The largest PepperLime Health Acquisition Corporation Class A Ordinary Share seller in Q4 2022 was Karpus Investment Management, an estimated $4.15M sold.

Based on aggregated 13F filings for Q4 2022.